Industry News

Biostar Pharmaceuticals reported on Wednesday that it has entered into a securities purchase agreement with certain institutional investors for the sale of 425,000 shares of common stock in a registered direct offering at the price of USD4.50 per share. In conjunction, the investors will receive warrants to purchase 212,500 shares of common stock. Under the terms of the offering, the warrants will be exercisable six months and one day from the date of..."/>
Biostar agrees USD1.91m registered direct offering of shares and warrants
Daily Mail, London, market report column [Daily Mail, London]
Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced the closing of its previously announced underwritten public offering of 2,475,248 shares of its common stock, plus 277,389 additional shares sold pursuant to the underwriter’ s partial exercise of its option to purchase additional shares, each at a price to the public of $10.10 per share. Including this option exercise, the..."/>
Cidara Therapeutics Announces Closing of Public Offering of Common Stock, Including Exercise of Underwriter’s Option to Purchase Additional Shares
Aethlon Medical, Inc., announced today that it has completed multiple milestone achievements under a contract with the Defense Advanced Research Projects Agency, including a milestone validation that the Aethlon Hemopurifier ® is able to capture the Middle East Respiratory Syndrome Coronavirus. The Hemopurifier ® is a first-in-class medical device designed to rapidly eliminate viral pathogens from the circulatory system of..."/>
Aethlon Medical Achieves DARPA Milestones, Including Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Validation
Allergan plc announced today a collaboration with SonarMD ®, a leader in population health management, on the development of clinical decision support and patient engagement tools which can be used to facilitate physician identification of patients suffering from Irritable Bowel Syndrome with Diarrhea in clinical practice and monitor their treatment outcomes. Moreover, the companies will establish a patient engagement platform which..."/>
Allergan Partners with SonarMD® to Develop Innovative IBS-D Patient Engagement Platform for Better Identification and Care of IBS-D Patients
CohBar, Inc., an innovative biotechnology company focused on developing mitochondria based therapeutics to treat diseases associated with aging, today announced the discovery of a large number of new biologically active peptides encoded within the genome of the mitochondria, together with the filing of 25 new provisional patent applications. The company is evaluating these..."/>
CohBar, Inc. Announces Discovery of New Peptides in the Mitochondrial Genome
CPSI Names William J. Hayes, M.D., Medical Director
Exactech, Inc., a developer and producer of bone and joint restoration products for extremities, hip, knee, and spine, announced today a successful first surgery using its new Vantage ® Total Ankle System, the newest addition to the Exactech extremities product line and its first product in the foot and ankle market. Orthopaedic surgeons Mark Easley, MD, and James Nunley, MD, of Duke University,..."/>
Exactech Breaks Ground in Foot and Ankle Market with Successful First Surgery
Ligand Pharmaceuticals Incorporated announced today plans to report third quarter 2016 financial results on November 3, 2016. Ligand’ s CEO John Higgins, President and COO Matt Foehr and CFO Matt Korenberg will host the conference call. Ligand also announced participation in the upcoming Stephens Fall Investment Conference."/>
Ligand Announces Third Quarter 2016 Earnings Release Date and Participation in the Stephens Fall Investment Conference
PAREXEL International Corporation will release financial results for First Quarter Fiscal Year 2017 on Wednesday, October 26, 2016 after the close of the stock market. PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, October 27, 2016, to discuss the results. To access the webcast, visit the Investor Section of PAREXEL’ s website at"/>
PAREXEL International Announces Date of First Quarter Fiscal Year 2017 Earnings Release and Conference Call
Five Star Quality Care, Inc. commenced on October 6, 2016 by ABP Acquisition LLC, an entity controlled by Barry M. Portnoy and Adam D. Portnoy. Senior Star announced that it intends to commence a tender offer through an affiliated entity for up to 10,000,000 shares of the Company's common stock in the coming days at a..."/>
Senior Star Announces Intention to Commence Tender Offer for up to 10,000,000 Shares of Five Star Quality Care Common Stock at $3.45 Per Share in Cash
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company with a focus on Pain and CNS conditions, today announced that its Board of Directors unanimously approved a reverse split of its common stock at a ratio of 1- for-10 and a majority voting standard for the election of directors in uncontested elections.. Reverse Stock Split As of the effective date of the reverse split, each share of issued and outstanding common stock and..."/>
Pernix Therapeutics Announces Reverse Stock Split and Corporate Governance Enhancements
Medpace has selected Montrium's eTMF Connect and RegDocs Connect solutions for the management of Medpace' clinical and regulatory documentation, improving clinical trial efficiency via a cloud-based document solution and enhancing their technology platform. Combined, these solutions form a comprehensive Electronic Document Management System. "Medpace selected Montrium after evaluating several EDMS..."/>
Medpace Selects Montrium Connect EDMS to Improve Clinical Trial Efficiency and Support its Continued Global Business Growth
Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the production and dispensing of high-quality innovative compounded medications, today announced events featuring its ophthalmic formulations at the annual American Academy of Ophthalmology meeting held October 15-18 in Chicago, IL. AAO, a global community of 32,000 members, is the world's largest association of eye physicians and surgeons. Mark L. Baum, CEO of Imprimis,..."/>
Imprimis Pharmaceuticals' Formulations to be Highlighted at Upcoming Annual Ophthalmology Meeting in Chicago
Kite Pharma, Inc. today announced the appointment of Chris Nowers as its Head of Europe. Nowers will be based in London. In his new role, Nowers will oversee European commercial operations to build awareness in the region of Kite’ s growing pipeline portfolio of chimeric antigen receptor and T-cell receptor therapy product candidates and prepare for the potential launch of the company’ s lead product candidate, KTE-C19."/>
Kite Pharma Appoints Chris Nowers as Head of Europe to Lead Commercial Operations and Advance the Company’s CAR/TCR Therapy Portfolio in the Region
ViewRay, Inc., makers of the world's first and only clinical MRI-guided radiation therapy system, announced today highlights from the recent 2016 Annual Meeting of the American Society for Radiation Oncology, which featured extensive clinical experience with the company's MRIdian System, as well research highlighting the MRIdian linear accelerator technology. As part of ASTRO's Scientific Sessions, 19 MRIdian clinical presentations..."/>
MRIdian Clinical Outcomes Data and Adaptive Capabilities: Highlights from ASTRO 2016
DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that the Company and its research collaborators have been invited to present data regarding the progress of VAL-083 at the following upcoming peer-reviewed scientific conferences:. European Association of NeuroOncology Annual Meeting; AACR DNA..."/>
DelMar Pharmaceuticals Announces Upcoming Scientific Conference Presentations
WellCare Health Plans, Inc. announced today that it named Elizabeth Miller state president, Florida, effective Oct. 15. She will have responsibility for WellCare's Medicaid and Medicare Advantage businesses across the state, including strategy, regulatory compliance, network management, sales and marketing, medical management, finance and administration. Miller will report to Gregg MacDonald, who has taken a broader role at WellCare as a..."/>
WellCare Names Elizabeth Miller State President, Florida
Cerus Corporation announced today that The Community Blood Center of Appleton, Wisconsin has submitted the first Biologics License Application to the U.S. Food and Drug Administration requesting allowance for interstate distribution of platelets that have been pathogen-reduced via the INTERCEPT Blood System. “We look forward to the FDA’ s review of our application, and our ability to supply INTERCEPT-treated platelets to hospital customers outside of..."/>
Cerus Announces First U.S. Blood Center Customer Submits Biologics License Application to the FDA to Allow for Interstate Export of INTERCEPT Platelet Components
SIGA Technologies, Inc. today announced that Dr. Phil Gomez has been appointed the company’ s new Chief Executive Officer. Eric Rose will become Executive Chairman of the Board of Directors."/>
SIGA Announces Dr. Phil Gomez Joins Company as New CEO, Dr. Eric Rose to Serve as Executive Chairman of the Board
Cellectar Biosciences, Inc., an oncology-focused, clinical stage biotechnology company, today announces that Jarrod Longcor, senior vice president of corporate development and operations, will present at the BIO Investor Forum in San Francisco on October 18, 2016.. The company’ s presentation at the BIO Investor Forum will be held at 1:30 PM PT in the Elizabethan B Room of the Westin St. Francis on 335 Powell Street in San Francisco, CA."/>
Cellectar Biosciences To Present at BIO Investor Forum

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology997 Articles
Consumer Discretionary813 Articles
Financials718 Articles
Health Care609 Articles
Industrials559 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at